Paley Jeffrey's Form 4 filing
Journey Medical Corp (DERM) · filed Dec 8, 2023
- Accession no.
- 0001104659-23-124743
- Filed
- Dec 8, 2023
- Trade date
- Nov 7-8, 2023
- Filing delay
- 31 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $8.77K. It was filed 31 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Paley JeffreyCIK 0001595327 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2023 | Common Stock, par value $0.0001 per share | SSaleDisposed | −2,245 | $3.48 | −$7,812.6 | 114,472 | Direct | |
| Nov 8, 2023 | Common Stock, par value $0.0001 per share | SSaleDisposed | −255 | $3.76 | −$958.8 | 114,217 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.